These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32300936)

  • 1. Hemophagocytic Lymphohistiocytosis Occurring in Inflammatory Bowel Disease: Systematic Review.
    Coburn ES; Siegel CA; Winter M; Shah ED
    Dig Dis Sci; 2021 Mar; 66(3):843-854. PubMed ID: 32300936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease.
    Hyams JS; Dubinsky MC; Baldassano RN; Colletti RB; Cucchiara S; Escher J; Faubion W; Fell J; Gold BD; Griffiths A; Koletzko S; Kugathasan S; Markowitz J; Ruemmele FM; Veereman G; Winter H; Masel N; Shin CR; Tang KL; Thayu M
    Gastroenterology; 2017 Jun; 152(8):1901-1914.e3. PubMed ID: 28193515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemophagocytic lymphohistiocytosis in inflammatory bowel disease: a nationwide analysis.
    Mahmoud AA; Abdelhay A; Khamis A; Mostafa M; Shehadah A; Mohamed MS; Eltaher B; Malik T
    Ann Hematol; 2023 Jul; 102(7):1705-1711. PubMed ID: 37093242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies.
    Brito-Zerón P; Bosch X; Pérez-de-Lis M; Pérez-Álvarez R; Fraile G; Gheitasi H; Retamozo S; Bové A; Monclús E; Escoda O; Moreno A; López-Guillermo A; Khamashta MA; Ramos-Casals M;
    Semin Arthritis Rheum; 2016 Feb; 45(4):391-9. PubMed ID: 26277577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review: hepatosplenic T-cell lymphoma on biologic therapy for inflammatory bowel disease, including data from the Food and Drug Administration Adverse Event Reporting System.
    Shah ED; Coburn ES; Nayyar A; Lee KJ; Koliani-Pace JL; Siegel CA
    Aliment Pharmacol Ther; 2020 Mar; 51(5):527-533. PubMed ID: 31990422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease.
    Torres J; Boyapati RK; Kennedy NA; Louis E; Colombel JF; Satsangi J
    Gastroenterology; 2015 Dec; 149(7):1716-30. PubMed ID: 26381892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are Biologics Safe in the Immediate Postoperative Period? A Single-Center Evaluation of Consecutive Crohn's Surgical Patients.
    Lightner AL; Grass F; Alsughayer AM; Harmsen WS; Petersen M; Loftus EV
    Dis Colon Rectum; 2020 Jul; 63(7):934-943. PubMed ID: 32149787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in pediatric Inflammatory Bowel Disease: clinical characteristics and outcomes.
    Bramuzzo M; Cananzi M; Alvisi P; Cardile S; Romano C; Aloi M; Arrigo S; Felici E; Lonoce L; Pieri ES; Scarallo L; Strisciuglio C; Di Siena A; Lega S
    Eur J Pediatr; 2024 Dec; 183(12):5411-5418. PubMed ID: 39404873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis.
    Borren NZ; Ananthakrishnan AN
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1736-1743.e4. PubMed ID: 30616024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Crohn's disease, thiopurines, and primary epstein-barr virus infection with hemophagocytic lymphohistiocytosis.
    Biank VF; Sheth MK; Talano J; Margolis D; Simpson P; Kugathasan S; Stephens M
    J Pediatr; 2011 Nov; 159(5):808-12. PubMed ID: 21722918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe CMV-related pneumonia complicated by the hemophagocytic lymphohistiocytic (HLH) syndrome in quiescent Crohn's colitis: harmful cure?
    Presti MA; Costantino G; Della Torre A; Belvedere A; Cascio A; Fries W
    Inflamm Bowel Dis; 2011 Nov; 17(11):E145-6. PubMed ID: 21826767
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of Cancer in Paediatric onset Inflammatory Bowel Diseases: A Nation-wide Study From the epi-IIRN.
    Atia O; Harel S; Ledderman N; Greenfeld S; Kariv R; Dotan I; Balicer R; Silverman B; Matz E; Levi Z; Waterman M; Fried I; Rowe JM; Turner D
    J Crohns Colitis; 2022 Jun; 16(5):786-795. PubMed ID: 34791097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prior Immunogenicity to Anti-TNF Biologics Is Not Associated with Increased Anti-drug Antibodies to Vedolizumab or Ustekinumab.
    Costable NJ; Borman ZA; Ji J; Dubinsky MC; Ungaro RC
    Dig Dis Sci; 2022 Jun; 67(6):2480-2484. PubMed ID: 34021427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
    Soy M; Atagündüz P; Atagündüz I; Sucak GT
    Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome - a systematic review.
    Krei JM; Møller HJ; Larsen JB
    Clin Exp Immunol; 2021 Feb; 203(2):174-182. PubMed ID: 33128796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Infliximab in Crohn's Disease Patients with Prior Primary-Nonresponse to Tumor Necrosis Factor Antagonists.
    Clark-Snustad KD; Singla A; Lee SD
    Dig Dis Sci; 2019 Jul; 64(7):1952-1958. PubMed ID: 30815825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemophagocytic Lymphohistiocytosis and Inflammatory Bowel Disease: Case Report and Systematic Review.
    Brambilla B; Barbosa AM; Scholze CDS; Riva F; Freitas L; Balbinot RA; Balbinot S; Soldera J
    Inflamm Intest Dis; 2020 Jun; 5(2):49-58. PubMed ID: 32596254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No Benefit of Concomitant Immunomodulator Therapy on Efficacy of Biologics That Are Not Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases: A Meta-analysis.
    Yzet C; Diouf M; Singh S; Brazier F; Turpin J; Nguyen-Khac E; Meynier J; Fumery M
    Clin Gastroenterol Hepatol; 2021 Apr; 19(4):668-679.e8. PubMed ID: 32629124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemophagocytic Lymphohistiocytosis Associated With Cytomegalovirus Infection: 5 Cases and a Systematic Review of the Literature.
    Chevalier K; Schmidt J; Coppo P; Galicier L; Noël N; Lambotte O
    Clin Infect Dis; 2023 Jan; 76(2):351-358. PubMed ID: 35974465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemophagocytic lymphohistiocytosis following pembrolizumab and bevacizumab combination therapy for cervical cancer: a case report and systematic review.
    Zhai C; Jin X; You L; Yan N; Dong J; Qiao S; Zhong Y; Zheng Y; Pan H
    BMC Geriatr; 2024 Jan; 24(1):32. PubMed ID: 38191289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.